Joshi delivered the ThaneVashi Oration in Nashik, focused on nutritional considerations for people on GLP-1 treatment.
Recap by typeshit. Post by Dr. Shashank Joshi on X.
The MFDS approval rests on SURPASS-CVOT, where Mounjaro matched Trulicity on heart events in 13,000+ patients but did not prove superior.
Inside Retail Asia looks at skincare and aesthetic treatments brands are building for facial volume loss after rapid weight loss.
The actor told an interviewer people can take Ozempic carefree, while stressing that nothing replaces actually working out.
CFO MV Narasimham says the company still expects to ship 6 to 7 million pens across 10 approved markets between November and March, with Canada taking most of them.
The obesity doctor takes on why some people see weaker results on GLP-1 medications. Short clip with few details given.
A weekly Substack live answers whether tirzepatide has a weight loss ceiling and how to handle plateaus and emotional eating when appetite is low.
Loading…